As regulatory pressure and rising drug costs reshape expectations for pharmacy benefit managers (PBMs), real-time data is becoming central to how PBMs build trust and retain clients. Payers are facing ...
The recent dismissal of an employee-led class action lawsuit against Johnson & Johnson (J&J), which alleged mismanagement of the health plan's prescription drug benefit, might give health plan ...
Early 2026 marks a coordinated turning point in the federal regulation and oversight of pharmacy benefit managers (PBMs), and these new PBM rules have significant fiduciary implications for ERISA ...
Over the past few years, Congress has attempted to pass “federal PBM reform.” Members of Congress have held numerous hearings related to PBMs and introduced numerous bills seeking to regulate PBMs (we ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. If you’re frustrated with your pharmacy benefit manager ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results